Loading...
Market
What will research conclude about sleep meds and Alzheimer's risk by end of 2025?
2
Resolution / Starting Odds
Confirmed link in humans • 25%
No link found • 25%
Link confirmed but only in specific populations • 25%
Research inconclusive • 25%
Scientific publications and research findings
Story
Study Links Common Sleep Medications to Impaired Brain Cleansing and 60% Increased Alzheimer's Risk for APOE e4 Gene Carriers
Jan 9, 2025, 07:05 AM
Recent studies indicate that sleep plays a crucial role in the brain's ability to remove waste, functioning as a 'rinse cycle' that flushes out toxins accumulated during wakefulness. However, research conducted on mice has found that certain common sleeping medications may hinder this cleansing process, potentially increasing the risk of Alzheimer's disease. Specifically, some of the most widely used sleep aids in Spain have been linked to brain damage and a higher likelihood of Alzheimer's. Additionally, a study highlighted that women taking Hormone Replacement Therapy (HRT) and possessing the APOE e4 gene may face a 60% increased risk of Alzheimer's-related markers. The findings underscore the importance of understanding the implications of sleep aids and hormone treatments on brain health.
View original story
Similar markets
Pfizer • 25%
Sanofi • 25%
Roche • 25%
Other • 25%
Yes • 50%
No • 50%
Highly effective • 25%
Moderately effective • 25%
Not effective • 25%
Slightly effective • 25%
No • 50%
Yes • 50%
3 or more • 25%
0 • 25%
1 • 25%
2 • 25%
Yes • 50%
No • 50%
4-5 new treatments • 25%
0-1 new treatments • 25%
2-3 new treatments • 25%
More than 5 new treatments • 25%
Yes • 50%
No • 50%
United States • 25%
Spain • 25%
Denmark • 25%
Other • 25%
Negative results • 25%
No significant results • 25%
Moderate positive results • 25%
Significant positive results • 25%